Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
TECH Analyst Ratings
Moderate Buy
8 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TECH Stock 12 Month Forecast
Average Price Target
$68.80
▲(37.93%Upside)
| Highest Price Target$90.00 | Average Price Target$68.80 | Lowest Price Target$51.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$57
Buy
14.27%
Upside
Reiterated
05/14/25
Bio-Techne demonstrates robust financial health with strong profitability and low leverage. However, technical indicators suggest bearish momentum, and high valuation raises concerns. The company navigates well through macroeconomic challenges as highlighted in the earnings call, but ongoing legal and tariff issues present risks.
Benchmark Co.
$75
Buy
50.36%
Upside
Reiterated
06/05/25
Wells Fargo
$59
Buy
18.28%
Upside
Initiated
05/30/25
Argus Research
$90→$65
Buy
30.31%
Upside
Reiterated
05/30/25
UBS
$95→$70
Buy
40.34%
Upside
Reiterated
05/09/25
Stifel Nicolaus
$60
Hold
20.29%
Upside
Reiterated
05/08/25
William Blair
―
Buy
―
Reiterated
05/07/25
Leerink Partners
$80
Buy
60.38%
Upside
Reiterated
05/07/25
Robert W. Baird
$68→$51
Buy
2.25%
Upside
Reiterated
04/21/25
KeyBanc
$90
Hold
80.43%
Upside
Downgraded
04/08/25
Evercore ISI
$75
Buy
50.36%
Upside
Initiated
03/18/25
Citi
$80→$70
Hold
40.34%
Upside
Reiterated
03/04/25
Scotiabank
$90
Buy
80.43%
Upside
Reiterated
02/06/25
Deutsche Bank
$84
Buy
68.40%
Upside
Assigned
08/08/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$57
Buy
14.27%
Upside
Reiterated
05/14/25
Bio-Techne demonstrates robust financial health with strong profitability and low leverage. However, technical indicators suggest bearish momentum, and high valuation raises concerns. The company navigates well through macroeconomic challenges as highlighted in the earnings call, but ongoing legal and tariff issues present risks.
Benchmark Co.
$75
Buy
50.36%
Upside
Reiterated
06/05/25
Wells Fargo
$59
Buy
18.28%
Upside
Initiated
05/30/25
Argus Research
$90→$65
Buy
30.31%
Upside
Reiterated
05/30/25
UBS
$95→$70
Buy
40.34%
Upside
Reiterated
05/09/25
Stifel Nicolaus
$60
Hold
20.29%
Upside
Reiterated
05/08/25
William Blair
―
Buy
―
Reiterated
05/07/25
Leerink Partners
$80
Buy
60.38%
Upside
Reiterated
05/07/25
Robert W. Baird
$68→$51
Buy
2.25%
Upside
Reiterated
04/21/25
KeyBanc
$90
Hold
80.43%
Upside
Downgraded
04/08/25
Evercore ISI
$75
Buy
50.36%
Upside
Initiated
03/18/25
Citi
$80→$70
Hold
40.34%
Upside
Reiterated
03/04/25
Scotiabank
$90
Buy
80.43%
Upside
Reiterated
02/06/25
Deutsche Bank
$84
Buy
68.40%
Upside
Assigned
08/08/24
Best Analysts Covering Bio-Techne
1 Month
xxx
Success Rate
24/35 ratings generated profit
Average Return
+1.72%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.57% of your transactions generating a profit, with an average return of +1.72% per trade.
3 Months
xxx
Success Rate
9/15 ratings generated profit
Average Return
+0.63%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +0.63% per trade.
1 Year
Success Rate
19/35 ratings generated profit
Average Return
+9.18%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 54.29% of your transactions generating a profit, with an average return of +9.18% per trade.
2 Years
xxx
Success Rate
17/35 ratings generated profit
Average Return
+16.20%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 48.57% of your transactions generating a profit, with an average return of +16.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TECH Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
1
3
4
Buy
6
7
8
6
5
Hold
5
5
7
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
16
15
15
Each month's total comprises the sum of three months' worth of ratings.
TECH Financial Forecast
TECH Stock Forecast FAQ
What is TECH’s average 12-month price target, according to analysts?
Based on analyst ratings, Bio-Techne’s 12-month average price target is 68.80.
What is TECH’s upside potential, based on the analysts’ average price target?
Bio-Techne has 37.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TECH a Buy, Sell or Hold?
Bio-Techne has a consensus rating of Moderate Buy which is based on 8 buy ratings, 3 hold ratings and 0 sell ratings.
What is Bio-Techne’s price target?
The average price target for Bio-Techne is 68.80. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $90.00 ,the lowest forecast is $51.00. The average price target represents 37.93% Increase from the current price of $49.88.
The highest analyst price target is $90.00 ,the lowest forecast is $51.00. The average price target represents 37.93% Increase from the current price of $49.88.
What do analysts say about Bio-Techne?
Bio-Techne’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of TECH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.